Transaction DateRecipientSharesTypePriceValue
19th November 2020W Thorpe Mckenzie375,000Open or private sale$18.30$6,862,500.00
18th September 2020John Simard500,000Other acquisition or disposition$0.00
15th September 2020Sushma Shivaswamy20,668Open or private sale$20.00$413,360.00
15th September 2020Sushma Shivaswamy20,668Exercise of derivative$7.50$155,010.00
10th September 2020Sushma Shivaswamy19,332Exercise of derivative$7.50$144,990.00
10th September 2020Sushma Shivaswamy19,332Open or private sale$20.01$386,833.32
1st September 2020Queena Han27,692Exercise of derivative$4.16$115,198.72
1st September 2020Queena Han30,000Exercise of derivative$4.24$127,200.00
24th August 2020Queena Han18,700Open or private sale$19.65$367,535.41
24th August 2020Queena Han18,700Exercise of derivative$7.50$140,250.00
X Biotech
X Biotech logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.


XBiotech, Inc. is a biopharmaceutical company. Its product pipeline include oncology, infectious diseases, dermatology, and inflammatory disorders.


Ticker: XBIT
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1626878
Employees: 53
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $230 M (0%)
Assets, Current: $258 M (-63%)
Property, Plant and Equipment, Net: $25 M (0%)
Assets: $359 M (-56%)
Accounts Payable, Current: $5 M (143%)
Accrued Liabilities, Current: $5 M (15%)
Liabilities, Current: $14 M (-76%)
Liabilities: $15 M (-75%)
Common Stock, Value, Issued: $246 M (-24%)
Retained Earnings (Accumulated Deficit): $97 M (-77%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $137 Th (29%)
Stockholders' Equity (Parent): $344 M (0%)
Liabilities and Equity: $359 M (-56%)
Cost of Revenue: $13 M (-42%)
Gross Margin: $2 M (-56%)
Research and Development: $3 M (-31%)
General and Administrative Expenses: $6 M (-39%)
Operating Income/Loss: $7 M (-24%)
Other Income, net: $662 Th (-42%)
Provision for income taxes: $332 Th (0%)